| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12K | -96.1% | -94.9% |
| Cost of Revenue | $11K | +21.1% | -42.1% |
| Gross Profit | $1K | -99.6% | -99.4% |
| R&D Expense | $2.6M | +16.6% | +96.6% |
| SG&A Expense | $1.1M | -18.8% | -5.7% |
| Operating Income | -$3.7M | -12.2% | -62.2% |
| Net Income | -$3.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $602K | -61.3% | -59.6% |
| Short-term Investments | $3.9M | -33.3% | -66.5% |
| Accounts Receivable | $13K | -10.7% | -91.9% |
| Current Assets | $4.7M | -38.0% | -65.2% |
| Total Assets | $5.6M | -33.7% | -61.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.4M | — | — |
| Capital Expenditures | $36K | — | — |
| Investing Cash Flow | $6.5M | — | — |
| Financing Cash Flow | $1.9M | — | — |
| Free Cash Flow | -$8.4M | — | — |
| -14.4% |
| -178.4% |
| EPS (Basic) | -$0.33 | -10.0% | -153.8% |
| EPS (Diluted) | -$0.33 | -10.0% | -153.8% |
| $3.4M |
| -6.4% |
| -25.0% |
| Stockholders' Equity | $2.2M | -54.5% | -77.9% |